<div class="tables frame-topbot rowsep-0 colsep-0" id="tbl2">
<div class="captions"><span id="cecap60"><p id="spara110"><span class="label">Table 2</span>. Primary and secondary cardiovascular outcomes</p></span></div>
<div class="groups"><table>
<thead>
<tr class="valign-bottom">
<th scope="col"></th>
<th scope="col"></th>
<th scope="col" class="align-left rowsep-1" colspan="2"><strong>Albiglutide (n=4731)</strong></th>
<th scope="col" class="align-left rowsep-1" colspan="2"><strong>Placebo (n=4732)</strong></th>
<th scope="col" class="align-left"><strong>Hazard ratio (95% CI)</strong></th>
<th scope="col" class="align-left">
<strong>p value</strong><a name="btbl2fn1" href="#tbl2fn1" class="workspace-trigger"><sup>*</sup></a>
</th>
</tr>
<tr class="valign-top rowsep-1">
<th scope="col"></th>
<th scope="col"></th>
<th scope="col" class="align-left">Number of patients (%)</th>
<th scope="col" class="align-left">Incidence rate (number of events per 100 person-years)</th>
<th scope="col" class="align-left">Number of patients (%)</th>
<th scope="col" class="align-left">Incidence rate (number of events per 100 person-years)</th>
<th scope="col"></th>
<th scope="col"></th>
</tr>
</thead>
<tbody>
<tr class="valign-bottom">
<td class="align-left" colspan="2">Primary composite outcome<a name="btbl2fn2" href="#tbl2fn2" class="workspace-trigger"><sup>†</sup></a>
</td>
<td class="align-left">338 (7%)</td>
<td class="align-left">4·57</td>
<td class="align-left">428 (9%)</td>
<td class="align-left">5·87</td>
<td class="align-left">0·78 (0·68–0·90)</td>
<td class="align-left">&lt;0·0001, 0·0006</td>
</tr>
<tr class="valign-top"><td class="align-left" colspan="8">Secondary outcomes</td></tr>
<tr class="valign-bottom">
<td></td>
<td class="align-left">Expanded composite outcome<a name="btbl2fn3" href="#tbl2fn3" class="workspace-trigger"><sup>‡</sup></a>
</td>
<td class="align-left">373 (8%)</td>
<td class="align-left">5·06</td>
<td class="align-left">468 (10%)</td>
<td class="align-left">6·45</td>
<td class="align-left">0·78 (0·69–0·90)</td>
<td class="align-left">0·0005</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Death from cardiovascular causes</td>
<td class="align-left">122 (3%)</td>
<td class="align-left">1·61</td>
<td class="align-left">130 (3%)</td>
<td class="align-left">1·72</td>
<td class="align-left">0·93 (0·73–1·19)</td>
<td class="align-left">0·578</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Fatal or non-fatal myocardial infarction</td>
<td class="align-left">181 (4%)</td>
<td class="align-left">2·43</td>
<td class="align-left">240 (5%)</td>
<td class="align-left">3·26</td>
<td class="align-left">0·75 (0·61–0·90)</td>
<td class="align-left">0·003</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Fatal or non-fatal stroke</td>
<td class="align-left">94 (2%)</td>
<td class="align-left">1·25</td>
<td class="align-left">108 (2%)</td>
<td class="align-left">1·45</td>
<td class="align-left">0·86 (0·66–1·14)</td>
<td class="align-left">0·300</td>
</tr>
<tr class="valign-top">
<td></td>
<td class="align-left">Composite of death from cardiovascular causes or hospital admission for heart failure</td>
<td class="align-left">188 (4%)</td>
<td class="align-left">2·49</td>
<td class="align-left">218 (5%)</td>
<td class="align-left">2·92</td>
<td class="align-left">0·85 (0·70–1·04)</td>
<td class="align-left">0·113</td>
</tr>
<tr class="valign-top">
<td class="align-left" colspan="2">Death from any cause</td>
<td class="align-left">196 (4%)</td>
<td class="align-left">2·44</td>
<td class="align-left">205 (4%)</td>
<td class="align-left">2·56</td>
<td class="align-left">0·95 (0·79–1·16)</td>
<td class="align-left">0·644</td>
</tr>
</tbody>
</table></div>
<p class="legend"></p>
<p id="spara120">Hazard ratios and p values were estimated with a Cox proportional hazards model with treatment as the sole explanatory variable.</p>
<dl class="footnotes">
<dt id="tbl2fn1">*</dt>
<dd><p id="cenpara20">Data
 for the primary outcome are the p value for non-inferiority, p value 
for superiority; all other p values are nominal p values for 
superiority.</p></dd>
<dt id="tbl2fn2">†</dt>
<dd><p id="cenpara30">Included death from cardiovascular causes (102 patients in the albiglutide group <em>vs</em> 109 patients in the placebo group), non-fatal myocardial infarction (160 patients <em>vs</em> 228 patients), or non-fatal stroke (76 patients <em>vs</em> 91 patients).</p></dd>
<dt id="tbl2fn3">‡</dt>
<dd><p id="cenpara40">Included
 death from cardiovascular causes, non-fatal myocardial infarction, 
non-fatal stroke, or urgent coronary revascularisation for unstable 
angina.</p></dd>
</dl>
</div>
